BIOTECNOLOGÍA DE NUTRACÉUTICOS Y COMPUESTOS BIOACTIVOS
BIONUC
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (7)
2024
2023
-
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Biomedicine and Pharmacotherapy, Vol. 162
-
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Redox Biology, Vol. 62
-
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Free Radical Biology and Medicine, Vol. 209, pp. 127-134
-
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Biomedicines, Vol. 11, Núm. 1
2022
-
Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models
International Journal of Molecular Sciences, Vol. 23, Núm. 12
2019
-
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
Scientific Reports, Vol. 9, Núm. 1